遺伝子治療:IL2RGはT細胞発育において腫瘍性であるのか?
Karin Pike-Overzet1, Dick de Ridder, Floor Weerkamp
1Department of Immunology, Erasmus University Medical Center, 3015 GE Rotterdam, The Netherlands.
Nature
|September 22, 2006
まとめ
X-リンクされた重症結合免疫不全 (X-SCID) のインターレウキン-2受容体ガンマ鎖 (IL2RG) 遺伝子治療は,直接腫瘍発生的ではない可能性があります. 代わりに,回復したシグナリングはT細胞の発達を可能にし,LMO2のような腫瘍遺伝子が白血病を促進することを可能にします.
科学分野:
- 免疫学 免疫学とは
- 腫瘍学 腫瘍学
- 遺伝子療法の遺伝子治療法
背景:
- X関連重症複合免疫不全 (X-SCID) は,インタールヒキン-2受容体の機能に不可欠なIL2RG遺伝子の変異によって引き起こされます.
- 以前の研究では,IL2RGの過剰発現が腫瘍原性であり,X-SCIDマウスモデルにおける胸腺腫瘍を引き起こす可能性があることが示唆されていた.
さらに関連する動画
10:03Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
Published on: November 11, 2016
7.9K
11:50Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function
Published on: November 4, 2016
11.6K
関連する概念動画
Gene Therapy
22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
